Lv2
144 积分 2022-08-24 加入
Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trial
2天前
已完结
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
3天前
已完结
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study
1个月前
已完结
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
1个月前
已完结
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
1个月前
已完结
Bezeotermin Alfa (rhBMP-6) Administration in Lumbar Interbody Fusion Surgery Using a Posterior Approach
4个月前
已完结
The effect of growth hormone injections on the costochondral junction of the rat rib
4个月前
已完结
Can EGFR be a therapeutic target in breast cancer?
4个月前
已完结
Epidermal growth factor receptor mutations in breast Cancer: Therapeutic challenges and way forward
4个月前
已完结
Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis
4个月前
已完结
皖公网安备34019202002308
